Chemed Price to Book Ratio 2010-2024 | CHE

Historical price to book ratio values for Chemed (CHE) over the last 10 years. The current price to book ratio for Chemed as of December 25, 2024 is 6.33.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Chemed Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2024-12-26 522.62 6.31
2024-09-30 600.43 $82.78 7.25
2024-06-30 541.62 $80.51 6.73
2024-03-31 640.79 $78.46 8.17
2023-12-31 583.32 $73.69 7.92
2023-09-30 518.08 $67.91 7.63
2023-06-30 539.56 $63.42 8.51
2023-03-31 535.28 $58.84 9.10
2022-12-31 507.72 $53.70 9.46
2022-09-30 433.91 $48.73 8.90
2022-06-30 466.18 $46.16 10.10
2022-03-31 502.72 $44.74 11.24
2021-12-31 524.65 $41.79 12.55
2021-09-30 460.93 $50.87 9.06
2021-06-30 469.86 $55.59 8.45
2020-12-31 526.63 $56.65 9.30
2020-09-30 474.63 $50.48 9.40
2020-06-30 445.40 $47.39 9.40
2020-03-31 427.46 $43.28 9.88
2019-12-31 433.11 $45.58 9.50
2021-03-31 455.01 $58.51 7.78
2019-09-30 411.40 $42.21 9.75
2019-06-30 355.25 $39.05 9.10
2019-03-31 314.82 $37.08 8.49
2018-12-31 278.38 $37.25 7.47
2018-09-30 313.76 $35.67 8.80
2018-06-30 315.65 $34.76 9.08
2018-03-31 267.41 $31.98 8.36
2017-12-31 237.91 $33.69 7.06
2017-09-30 197.56 $30.08 6.57
2017-06-30 199.70 $28.48 7.01
2017-03-31 178.14 $31.30 5.69
2016-12-31 156.19 $32.38 4.82
2016-09-30 137.10 $30.22 4.54
2016-06-30 132.23 $28.69 4.61
2016-03-31 131.16 $29.46 4.45
2015-12-31 144.79 $30.55 4.74
2015-09-30 128.80 $29.12 4.42
2015-06-30 126.30 $28.41 4.45
2015-03-31 114.83 $28.07 4.09
2014-12-31 101.43 $26.72 3.80
2014-09-30 98.57 $25.57 3.86
2014-06-30 89.58 $25.86 3.46
2013-12-31 72.90 $25.53 2.86
2013-09-30 67.85 $24.34 2.79
2013-06-30 68.54 $25.93 2.64
2013-03-31 75.49 $25.73 2.93
2012-12-31 64.59 $24.46 2.64
2014-03-31 85.31 $25.57 3.34
2012-09-30 65.06 $24.73 2.63
2012-06-30 56.59 $23.55 2.40
2012-03-31 58.52 $22.71 2.58
2011-12-31 47.69 $21.71 2.20
2011-09-30 51.04 $21.55 2.37
2011-06-30 60.67 $22.97 2.64
2011-03-31 61.55 $21.91 2.81
2010-12-31 58.56 $21.71 2.70
2010-09-30 52.41 $23.51 2.23
2010-06-30 50.13 $22.61 2.22
2010-03-31 49.79 $21.91 2.27
2009-12-31 43.82 $21.10 2.08
2009-09-30 39.99 $20.26 1.97
2009-06-30 35.87 $19.42 1.85
2009-03-31 35.29 $18.56 1.90
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $7.824B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.525B 11.81
Quest Diagnostics (DGX) United States $17.124B 17.35
DaVita (DVA) United States $12.715B 16.44
Encompass Health (EHC) United States $9.488B 22.37
Elanco Animal Health (ELAN) United States $5.873B 13.98
RadNet (RDNT) United States $5.431B 120.26
Option Care Health (OPCH) United States $3.882B 18.40
LifeStance Health (LFST) United States $2.789B 0.00
Amedisys (AMED) United States $2.789B 19.85
Addus HomeCare (ADUS) United States $2.337B 27.42
Astrana Health (ASTH) United States $1.883B 25.75
U.S Physical Therapy (USPH) United States $1.362B 35.82
Pennant (PNTG) United States $0.925B 37.42
Aveanna Healthcare Holdings (AVAH) United States $0.854B 0.00
Atai Life Sciences (ATAI) Germany $0.206B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.038B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.006B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00